NYSE:GBS

GBS (GBS) Stock Price, News & Analysis

$0.47
0.00 (-0.04%)
(As of 10/26/2022)
Today's Range
$0.45
$0.49
50-Day Range
$2.47
$5.52
52-Week Range
$0.36
$2.89
Volume
11,000 shs
Average Volume
955,325 shs
Market Capitalization
$7.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GBS stock logo

About GBS Stock (NYSE:GBS)

GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

GBS Stock Price History

GBS Stock News Headlines

His win rate puts Warren Buffett to shame…
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
His win rate puts Warren Buffett to shame…
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
The Best Dell Deals for April 2024
Annexon: Unforced Error Sullies Prospects
See More Headlines
Receive GBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/31/2022
Today
4/28/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-8,310,000.00
Pretax Margin
-1,907.09%

Debt

Sales & Book Value

Annual Sales
$440,000.00
Book Value
$0.44 per share

Miscellaneous

Free Float
14,850,000
Market Cap
$40.05 million
Optionable
Not Optionable
Beta
1.32
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives


GBS Stock Analysis - Frequently Asked Questions

How have GBS shares performed in 2024?

GBS's stock was trading at $0.3379 on January 1st, 2024. Since then, GBS stock has increased by 40.0% and is now trading at $0.4732.
View the best growth stocks for 2024 here
.

How were GBS's earnings last quarter?

GBS Inc. (NYSE:GBS) posted its quarterly earnings data on Wednesday, August, 31st. The company reported ($0.14) earnings per share for the quarter, beating analysts' consensus estimates of ($0.18) by $0.04.

How do I buy shares of GBS?

Shares of GBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:GBS) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners